Theriva Biologics, Inc. Current Federal Tax Expense (Benefit)
Theriva Biologics, Inc. (TOVX) reported Current Federal Tax Expense (Benefit) of -$3.04 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-16.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2022-03-16
- Theriva Biologics, Inc. current federal tax expense (benefit) for fiscal 2021 was -$3.04M.
- Theriva Biologics, Inc. current federal tax expense (benefit) for fiscal 2020 was -$2.12M.
- Theriva Biologics, Inc. current federal tax expense (benefit) for fiscal 2019 was -$3.23M.
- Theriva Biologics, Inc. current federal tax expense (benefit) for fiscal 2018 was -$2.82M.
| Period end | Current Federal Tax Expense (Benefit) 12 month |
|---|---|
| 2021-12-31 | -$3.04M 10-K · filed 2022-03-16 |
| 2020-12-31 | -$2.12M 10-K · filed 2022-03-16 |
| 2019-12-31 | -$3.23M 10-K · filed 2021-03-04 |
| 2018-12-31 | -$2.82M 10-K · filed 2020-02-20 |
| 2017-12-31 | -$5.27M 10-K · filed 2019-02-27 |
| 2016-12-31 | -$9.45M 10-K · filed 2018-02-22 |
| 2015-12-31 | -$14.87M 10-K · filed 2017-03-02 |
| 2014-12-31 | -$6.73M 10-K · filed 2016-03-10 |
| 2013-12-31 | -$4.19M 10-K · filed 2015-03-16 |
| 2012-12-31 | -$5.80M 10-K · filed 2015-03-16 |
| 2011-12-31 | -$2.62M 10-K · filed 2013-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |